Treatment of infection in burns

Total Burn Care

Volumn , Issue , 2007, Pages 136-176

  Gallagher, James J ^a   Williams Bouyer, Natalie ^a,b   Villarreal, Cynthia ^a   Heggers, John P ^a   Herndon, David N ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43149094768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3274-8.50015-5     Document Type: Chapter

References (105)

1. V Edwards-Jones, JE Greenwood and Manchester Burns Research Group (2003) What's new in burn microbiology? James Laing Memorial Prize Essay 2000. Burns 29 15-24.
2. CG Mayhall (2003) The epidemiology of burn wound infections: then and now. Clin Infect Dis 7 543-550.
3. BA Pruitt Jr, AT McManus and SH Kim (1998) Burn wound infections: current status. World J Surg 22 135-145.
4. MC Robson, TJ Krizek and JP Heggers (1973) Biology of surgical infection. MM Ravitch (Eds) Current problems in surgery Chicago: Yearbook Medical 1-62.
5. C Teplitz, D Davis, AD Mason, et al. (1964) Pseudomonas burn wound sepsis. Pathogenesis of experimental pseudomonas burn wound sepsis. J Surg Res 4 200-216.
6. MC Robson (1979) Bacterial control in the burn wound. Clin Plast Surg 6(4), 515-522.
7. CP Artz and JA Moncrief (1969) The treatment of burns Philadelphia: WB Saunders
8. JP Heggers and MC Robson (Eds) (1991) Quantitative bacteriology: its role in the armamentarium of the surgeon 1st edn. Boca Raton, FL: CRC 139.
9. C Teplitz (1979) The pathology of burn and fundamentals of burn wound sepsis. CP Artz, JA Moncrief, BA Pruitt, Jr (Eds) Burns: a team approach Philadelphia: WB Saunders 45-94.
10. JR Burke, WC Quinby, CC Bondoc, et al. (1977) The contribution of a bacterial isolated environment to the prevention of infection in seriously burned patients. Ann Surg 186 377-387.
11. R Perez-Cappelano, JC Manelli, D Dalayret, et al. (1976) Evaluation of the septicaemic risk by quantitative study of the cutaneous flora in patients with burns. Burns 3 42-45.
12. RL Sheridan (2005) Sepsis in pediatric burn patients. Pediatr Crit Care Med 6(3 Suppl), S112-S119.
13. U Altoparlak, S Erol, MN Akcay, et al. (2004) The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 30 660-664.
14. MC Robson (1988) Burn sepsis. Crit Care Clin 4(2), 281-298.
15. EJ Lowbury, JR Babb and PM Ford (1971) Protective isolation in a burn unit: the use of plastic isolators and air curtains. J Hyg 69(4), 529-546.
16. FC Nance, V Lewis and GH Bomside (1970) Absolute barrier isolation and antibiotics in the treatment of experimental burn wound sepsis. J Surg Res 10 33.
17. RT Sherman (1970) The prevention and treatment of tetanus in the burn patient. Surg Clin North Am 50 1277-1281.
18. JM Larkin and JA Moylan (1975) Tetanus following a minor burn. J Trauma 15 546-548.
19. D Tompkins, LA Rossi and Nursing Committee of the International Society for Burn Injuries (2004) Care of outpatient burns. Burns 30 A7-A9.
20. MC White, K Thornton and AER Young (2005) Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns 31 193-197.
21. BA Pruitt and FD Foley (1973) The use of biopsies in burn patient care. Surgery 73 887-897.
22. DH Parks, HA Linares and PD Thomson (1981) Surgical management of burn wound sepsis. Surg Gynecol Obstet 153 374-376.
23. MC Robson and TS Krizek (1973) Predicting skin graft survival. J Trauma 13(3), 213-217.
24. S Danilla, P Andrades, ME Gómez, et al. (2005) Concordance between qualitative and quantitative cultures in burned patients analysis of 2886 cultures. Burns 31 967-971.
25. JP Heggers, JA Sazy, BD Stenberg, et al. (1991) Bactericidal and wound healing properties of sodium hypochlorite. J Burn Care Rehabil 12(5), 420-424.
26. RC Fader, A Maurer, MD Stein, et al. (1983) Sodium hypochlorite decontamination of split-thickness cadaveric skin infected with bacteria and yeast with subsequent isolation and growth of basal cells to confluency in tissue culture. Antimicrob Agents Chemother 24 181-185.
27. HM Bruck, G Nash, FD Foley, et al. (1971) Opportunistic fungal infection of the burn wound with phycomycetes and Aspergillus. Arch Surg 102 476-482.
28. JP Barret, M Jeschke and DN Herndon (2001) Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 27 439-445.
29. TN Pham, AJ Warren, HH Pham, et al. (2005) Impact of tight glycemic control in severely burned children. J Trauma Inj Infect Crit Care 1148-1154.
30. MH Desai, DN Herndon and S Abston (1981) Candida infection in massively burned patients. J Trauma 21(3), 237-239.
31. K Kobayashi, N Mukae, Y Matsunaga, et al. (1990) Diagnostic value of serum antibody to Candida in an extensively burned patient. Burns 16(6), 414-417.
32. E Goldstein and PD Hoeprich (1980) Problems in the diagnosis and treatment of systemic conditions. J Infect Dis 125 190-193.
33. A Kidson and EJL Lowbury (1980) Candida infection of burns. Burns 6 228-230.
34. JJ Burdge, F Rea and L Ayers (1988) Noncandidal, fungal infections of the burn wound. J Burn Care Rehabil 9(6), 599-601.
35. JS Solom and RL Simmons (1980) Candida infection in surgical patients. World J Surg 4 381-394.
36. MJ Spebar and RB Lindberg (1981) Fungal infection of the burn wound. Am J Surg 21(3), 237-239.
37. JK Prasad, IF Feller and PD Thomson (1987) A ten-year review of Candida sepsis and mortality in burn patients. Surgery 101 213-216.
38. CC Linneman Jr and BC MacMillan (1983) Viral infections in pediatric burn patients. Am J Dis 135 750-753.
39. GS Deepe Jr, BC MacMillan and CC Linnemann Jr (1982) Unexplained fever in burned patients due to cytomegalovirus infection. JAMA 248 2299-2301.
40. CW Goodwin and WF McManus (1985) Viral infections in burned patients. Immunol 12 3-4. 8–9.
41. P Edgar, M Kravitz, JP Heggers, et al. (1990) Herpes simplex in pediatric burn patients. Proceedings of the American Burn Association 22 56.
42. WH Weintraub, AB Lilly and JG Randolph (1974) A chickenpox epidemic in a pediatric burn unit. Surgery 76 490-494.
43. JP Barrret, AN Dardano, JP Heggers, et al. (1999) Infestations and chronic infections in foreign pediatric patients with burns: is there a role for specific protocols? J Burn Care Rehabil 20 482-486.
44. PI Ramzy, DN Herndon, SE Wolf, et al. (1998) Comparison of organisms found by bronchoalveolar lavage and quantitative wound culture in severely burned children. Arch Surg 133 1275-1280.
45. GL Mandell, JE Bennett and R Dolin (Eds) (2004) 6th edn. Principles and practice of infectious diseases Vol 2 New York: Churchill Livingstone
46. CM Luna, P Vukacich, MS Niederman, et al. (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111 676-685.
47. MH Kollef (2000) Ventilator-associated pneumonia: the importance of initial empiric antibiotic selection. Infect Med 17(4), 265-268. 278–283.
48. BH Hamory (1989) Nosocomial sepsis related to intravascular access. Crit Care Nurs Q 11(4), 58-65.
49. W Samsoondar, JB Freeman, I Coultish, et al. (1985) Colonization of intravascular catheters in the intensive care unit. Am J Surg 149 730-732.
50. DG Maki, F Jarrett and HW Sarafin (1977) A semiquantitative culture method for identification of catheter related infection in the burn patient. J Surg Res 22 513-520.
51. JM Stein and BA Pruitt Jr (1970) Suppurative thrombophlebitis: a lethal iatrogenic disease. N Engl J Med 282 1452-1455.
52. D Franceschi, RL Gerding, G Phillips, et al. (1989) Risk factors associated with intravascular catheter infection in burned patients; a prospective randomized study. J Trauma 29(6), 811-816.
53. L Smallman, DW Burdon and J Alexander-Williams (1980) The effect of skin preparation and care on the incidence of superficial thrombophlebitis. Br J Surg 67 861-862.
54. NK Sheth, TR Franson, HD Rose, et al. (1983) Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 18 1061-1063.
55. DG Maki, JT Botticelli, ML LeRoy, et al. (1987) Prospective study of replacing administration sets for intravenous therapy at 48 to 72 hour intervals. JAMA 258 1777-1781.
56. BA Pruitt Jr, JM Stein, FD Foley, et al. (1970) Intravenous therapy in burn patients: suppurative thrombophebitis and other life threatening complications. Arch Surg 100 399-404.
57. TM Sasaki, GW Welch, DN Herndon, et al. (1979) Burn wound manipulation induced bacteremia. J Trauma 19(l), 46-48.
58. CH Beard, CD Ribeiro and DM Jones (1975) The bacteremia associated with burns surgery. Br J Surg 62 638-641.
59. S Mzezewa, K Jönsson, E Sibanda, M Åberg and L Salemark (2003) HIV infection reduces skin graft survival in burn injuries: a prospective study. Br J Plast Surg 56 740-745.
60. PR Murray, EJ Baron, JH Jorgensen, et al. (Eds) (2003) Manual of clinical microbiology 8th edn. Washington, DC: ASM
61. S Baron (1996) Medical microbiology 4th edn. Galveston, Texas: University of Texas Medical Branch
62. AT McManus, SH Kim, WF McManus, et al. (1987) Comparison of quantitative microbiology and histology in divided burn-wound biopsy specimens. Arch Surg 122 74-76.
63. CG Mayhall (Eds) (1996) Hospital epidemiology and infection control 1st edn. Baltimore, Maryland: Williams & Wilkins
64. Y Sedat, TZ Nursal, A Tarim, et al. (2005) Bacteriological profile and antibiotic resistance: comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center. J Burn Care Rehabil 26 488-492.
65. EW Koneman, SD Allen, WM Janda, et al. (Eds) (1997) Color atlas and textbook of diagnostic microbiology 5th edn. Philadelphia, Pennsylvania: Lippincott-Raven
66. GL Woods and Y Gutierrez (Eds) (1993) Diagnostic pathology of infectious diseases 1st edn. Malvern, Pennsylvania: Lea & Febiger
67. WK Becker, WG Cioffi Jr, AT McManus, et al. (1991) Fungal burn wound infection. A 10-year experience. Arch Surg 126(1), 44-48.
68. MH Desai, DN Herndon and S Abston (1981) Candida infection in massively burned patients. J Trauma 21(3), 237-239.
69. BA Pruitt Jr (1984) Phycomycotic infections. Probl Gen Surg 664-678.
70. RL Sheridan (2005) Sepsis in pediatric burn patients. Pediatr Crit Care Med 6(3), S112-S119.
71. J Martyn (1986) Clinical pharmacology and drug therapy in the burned patient. Anesthesiology 65 67-76.
72. GK McEvoy (Eds) (2003) American hospital formulary service Bethesda, MD: American Society of Health-System Pharmacists
73. CF Lacy, LL Armstrong, MP Goldman, et al. (2003) Drug information handbook 11th edn. Hudson, OH: Lexi
74. MJ Rybak (2006) The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42 S35-S75.
75. R Ramphal (2006) Developing strategies to minimize the impact of extended-spectrum β-lactamases: focus on cefepime. Clin Infect Dis 42 S151-S152.
76. DS McKinsey (2004) Making best use of the newer antifungal agents. Drug Benefit Trends 16 131-147.
77. ME Evans, DJ Feola and RP Rapp (1999) Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 33 960-967.
78. MC Robson (1977) The use of topical agents to control bacteria. AR Dimick (Eds) The burn wound in practical approaches to burn management Deerfield, IL: Flint Laboratories, Travenol 17-19.
79. JA Moncrief (1968) The status of topical antibacterial therapy in the treatment of burns. Surgery 63 862.
80. IO Kucan and EC Smoot (1993) Five percent mafenide acetate solution in the treatment of thermal injuries. J Burn Care Rehabil 14 158-163.
81. RB Lindberg, JA Moncrief and AD Mason Jr (1968) Control of experimental and clinical burn wound sepsis by topical application of sulfamylon compounds. Am NY Acad Sci 150 950.
82. LL Strock, M Lee, RL Rutan, et al. (1990) Topical Bactroban® (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. J Burn Care Rehabil 11(5), 109-116.
83. G Nash, FD Foley, MN Goodwin Jr, et al. (1971) Fungal burn wound infection. JAMS 215 1664-1666.
84. AT Fuller, G Mellows, et al. (1971) Pseudomonic acid, an antibiotic produced by Pseudomonas fluorescens. Nature (London) 234 416-417.
85. JP Heggers (1979) The use of antimicrobial agents. TJ Krizek, MC Robson (Eds) Clinics in plastic surgery Vol. 6 Philadelphia, PA: WB Saunders 545-551.
86. JP Heggers (1991) Antimicrobial agents. JB Heggers, MC Robson (Eds) Quantitative bacteriology: it's role in the armamentarium of the surgeon Boca Raton, FL: CRC 115-125.
87. JA Moncrief (1979) Topical antibacterial treatment of the burn wound. CP Artz, JA Moncrief, BA Pruitt, Jr (Eds) Burns, a team approach Philadelphia, PA: WB Saunders 250-269.
88. J Buchvald (1988) An evaluation of topical mupirocin in moderately severe primary and secondary skin infections. J Int Med Res 16 66-70.
89. DW Denning and D Haiduven-Griffiths (1988) Eradication of low-level resistant Staphylococcus aureus skin colonization with topical mupirocin. Infect Control Hosp Epidemiol 9(6), 261-263.
90. H Rode, PM DeWet, et al. (1988) Bacterial efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection. J Antimicrob Chemother 21 589-595.
91. BA Pruitt Jr and F Foley (1973) The use of biopsies in burn patient care. Surgery 73 8878-8897.
92. P Neame and D Rayner (1960) Mucormycosis: a report of 22 cases. Arch Pathol 70 261-268.
93. NG Georglade and WA Harris (1972) Open and closed treatment of burns with povidone-iodine. HC Polk, Jr,NJ Ebrenkranz (Eds) Therapeutic advances and new clinical impressions: medical and surgical antisepsis with betadine microbicides Yonkers, NY: Purdue Frederick
94. TJ Krizek, JH Davis, JD DesPrez, et al. (1967) Topical therapy of burns – experimental evaluation. Plast Reconstr Surg 39 248.
95. JP Heggers, MC Robson, DN Herndon, et al. (1989) The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. J Burn Care Rehabil 10 508-511.
96. TJ Krizek, N Koss and MC Robson (1975) The current use of prophylactic antibiotics in plastic and reconstructive surgery. Plast Reconstr Surg 55 21-32.
97. TJ Krizek, LJ Gottlieb, H Koss, et al. (1985) The use of prophylactic antibacterials in plastic surgery: a 1980s update. Plast Reconstr Surg 76 953-963.
98. JH Richards (1932) Bacteremica following irritation of foci of infection. JAMA 99 1496-1497.
99. J LeFrock, CA Ellis, JB Turchik, et al. (1973) Transient bacteremia associated with sigmoidoscopy. N Engl J Med 289 467-469.
100. JP Heggers, C Villarreal, P Edgar, et al. (1998) Ciprofloxacin, the quinolone as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated. Arch Surg 133 1247-1250.
101. JP Barret, PI Ramzy, JP Heggers, et al. (1999) Topical nystatin powder in severe burns: a new treatment for angioinvasive fungal infection refractory to other topical and systemic agents. Burns 25(6), 505-508.
102. JP Heggers, ST Barnes, MC Robson, et al. (1969) Microbial flora of orthopaedic war wounds. Milit Med 134 602.
103. D Scholz, W Scharmann and H Biobet (1974) Leucocidic substances for Aeromonas hydrophilia. Zentralbl Bakteriol [Orig A] 228 312-316.
104. MC Robson, WF Duke and TJ Krizek (1973) Rapid bacterial screening in the treatment of civilian wounds. J Surg Res 14 426.
105. IA Holder, M Schwab and L Jackson (1979) Eighteen months of routine topical antimicrobial susceptibility testing of isolates from burn patients: results and conclusions. J Antimicrob Chemother 5 455-463.